InflammaDry is revolutionizing the diagnosis of dry eye disease by rapidly detecting MMP-9 levels and identifying ocular inflammation. This non-invasive test enables eye care professionals to make informed treatment decisions quickly.
InflammaDry is a rapid, in-office diagnostic test designed to detect elevated levels of an inflammatory marker known as MMP-9 in the tears of patients with dry eye disease. This non-invasive test provides eye care professionals with vital information about inflammation on the ocular surface within minutes. By accurately identifying inflammation, InflammaDry guides treatment decisions that can improve patient outcomes and preserve long-term eye health.
InflammaDry is the first and only rapid, CLIA-waived test performed right in the office to help diagnose dry eye disease by detecting the presence of matrix metalloproteinase-9 (MMP-9) in tear samples. Unlike traditional tests that only evaluate tear production or stability, InflammaDry specifically identifies ocular surface inflammation as a key factor in dry eye. This simple, disposable test is designed to be both efficient and cost-effective, making it a valuable tool for modern eye care.
MMP-9 is an enzyme that plays a significant role in the breakdown of extracellular matrix proteins, and its elevated levels in tears are a strong indicator of inflammation on the ocular surface. In dry eye disease, changes in tear film composition and ocular inflammation can lead to a cascade of events that result in discomfort, redness, and tissue damage. By measuring the level of MMP-9, eye doctors can better understand the inflammatory status of the eye and decide whether a patient’s dry eye is primarily driven by inflammation or other factors.
This targeted approach is crucial because inflammation often appears before clinical signs of dry eye become apparent, allowing for earlier intervention. Recognizing elevated MMP-9 levels can be the first step toward a treatment plan designed to reduce inflammation, protect the ocular surface, and enhance overall visual comfort.
Find a top optometrist near you who utilizes InflammaDry to enhance your dry eye treatment and improve your quality of life.
The InflammaDry test is performed using a direct sampling microfiltration technology that collects a tear sample from the inside lining of the lower eyelid. Here’s a brief overview of the process:
This entire procedure is completed in about 10 minutes, enabling eye care professionals to quickly discuss results and treatment recommendations with the patient before they leave the office.
There are several reasons why InflammaDry has become a game-changer in the diagnosis and management of dry eye disease:
Find a top optometrist near you who utilizes InflammaDry to enhance your dry eye treatment and improve your quality of life.
InflammaDry is a fast, accurate test that detects MMP-9 levels to help diagnose dry eye disease and guide treatment decisions.
